Dupixent Disease Interactions
There are 3 disease interactions with Dupixent (dupilumab).
Dupilumab (applies to Dupixent) arthralgia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Psoriatic Arthropathy, Rheumatoid Arthritis
Arthralgia has been reported with the use of dupilumab. Patients should be advised to report new onset or worsening joint symptoms to their health care provider.
References (1)
- (2024) "Product Information. Dupixent Pre-filled Syringe (dupilumab)." sanofi-aventis, SUPPL-59
Dupilumab (applies to Dupixent) helminth infections
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
It is unknown if dupilumab with affect the immune response against helminth infections. Patients with preexisting helminth infections should be treated prior to therapy with dupilumab. If patients become infected while receiving dupilumab and do not respond to anthelminthic treatment, dupilumab should be discontinued until the infection resolves.
References (1)
- (2024) "Product Information. Dupixent Pre-filled Syringe (dupilumab)." sanofi-aventis, SUPPL-59
Dupilumab (applies to Dupixent) visual defects
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Visual Defect/Disturbance
Conjunctivitis and keratitis adverse reactions have been reported with dupilumab. Care should be exercised when using this agent in patients with visual defects. Patients or their caregivers should be advised to report new onset or worsening eye symptoms to their health care provider.
References (1)
- (2024) "Product Information. Dupixent Pre-filled Syringe (dupilumab)." sanofi-aventis, SUPPL-59
Switch to consumer interaction data
Dupixent drug interactions
There are 97 drug interactions with Dupixent (dupilumab).
More about Dupixent (dupilumab)
- Dupixent consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (515)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Eohilia
Eohilia (budesonide) suspension is used to treat eosinophilic esophagitis (EoE), to reduce symptoms ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Nucala
Nucala is used to treat severe eosinophilic asthma, eosinophilic COPD, chronic rhinosinusitis with ...
Temovate
Temovate is used for atopic dermatitis, dermatitis, dermatological disorders, eczema, lichen ...
Lidex
Lidex is used for atopic dermatitis, dermatitis, eczema, psoriasis
Clobex
Clobex is used for atopic dermatitis, dermatitis, dermatological disorders, eczema, lichen planus ...
Olux
Olux is used for atopic dermatitis, dermatitis, dermatological disorders, eczema, lichen planus ...
Lidex-E
Lidex-E is used for atopic dermatitis, dermatitis, eczema, psoriasis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.